| Income Statement |
| Total Revenue | 26.49M |
|
| Revenues (USD) | 26.49M |
| Cost of Revenue | 3.37M |
| Gross Profit | 23.12M |
| Operating Expenses | 43.87M |
| Research and Development Expense | 6.16M |
| Selling, General and Administrative Expense | 37.71M |
| Operating Income | -20.74M |
| Interest Expense | 434.00K |
| Net Income | -19.74M |
| Net Income Common Stock | -19.74M |
| Net Income Common Stock (USD) | -19.74M |
| Consolidated Income | -19.74M |
| Earnings per Basic Share | -0.52 |
| Earnings per Basic Share (USD) | -0.52 |
| Earnings per Diluted Share | -0.52 |
| Earning Before Interest & Taxes (EBIT) | -19.30M |
| Earning Before Interest & Taxes (USD) | -19.30M |
| Weighted Average Shares | 37.66M |
| Weighted Average Shares Diluted | 37.66M |
| Balance Sheet |
| Cash and Equivalents | 45.25M |
| Cash and Equivalents (USD) | 45.25M |
| Investments | 95.93M |
| Investments Current | 95.93M |
| Trade and Non-Trade Receivables | 15.71M |
| Current Assets | 168.91M |
| Property, Plant & Equipment Net | 3.97M |
| Total Assets | 178.08M |
| Debt Current | 1.14M |
| Total Debt | 22.12M |
| Current Liabilities | 16.18M |
| Debt Non-Current | 20.98M |
| Total Liabilities | 37.27M |
| Accumulated Retained Earnings (Deficit) | -240.09M |
| Accumulated Other Comprehensive Income | 18.00K |
| Shareholders Equity | 140.81M |
| Shareholders Equity (USD) | 140.81M |
| Assets Non-Current | 9.17M |
| Total Debt (USD) | 22.12M |
| Inventory | 6.90M |
| Liabilities Non-Current | 21.08M |
| Trade and Non-Trade Payables | 1.98M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 228.00K |
| Net Cash Flow from Financing | 1.63M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.78M |
| Capital Expenditure | -125.00K |
| Issuance (Purchase) of Equity Shares | 1.63M |
| Net Cash Flow from Investing | 22.44M |
| Net Cash Flow - Investment Acquisitions and Disposals | 23.27M |
| Net Cash Flow from Operations | -19.30M |
| Share Based Compensation | 3.72M |